The Mets placed right-hander Carlos Carrasco on the injured list earlier this week due to inflammation in his throwing elbow. The diagnosis got a little more clarity yesterday when the club announced to reporters, including Will Sammon of The Athletic, that Carrasco has a bone spur in his right elbow. He’ll be shut down for three to five days and then reevaluated. Manager Buck Showalter had previously informed reporters, including Sammon, that Carrasco would get an injection of some kind to try to alleviate the situation. Mike Puma of The New York Post reports that the hope is for the injection to allow Carrasco to continue pitching in two weeks, but he could be facing surgery otherwise.
This isn’t the first time Carrasco has been down this road, as he had surgery to remove a bone fragment from his pitching elbow in October of 2021. That was a different situation in terms of timing, however, as he then had an entire offseason to recover. Now that the 2023 campaign is in its early stages, the impacts of a surgery would be larger. It seems that he and the club are still hoping he can avoid going under the knife, but it would be a concerning development if he does ultimately require the procedure, given the overall state of the club’s rotation.
On paper, the Mets came into the year with a strong rotation, but one without certainty. It was set to be headlined by Max Scherzer and Justin Verlander, who are 38 and 40 years old, respectively. Then there was 34-year-old José Quintana and 36-year-old Carrasco, as well as Kodai Senga, who is only 30 but making the adjustment from Japan’s once-a-week pitching schedule to the more arduous North American system. There was plenty of talent there but also plenty of reasons to expect bumpy sections on the road to October.
Now just a few weeks into the season, there’s been plenty of wobbles already. Verlander has yet to debut due to a teres major strain while Quintana is out until July due to rib surgery. Carrasco made three starts before landing on the shelf but wasn’t very effective. Now Scherzer is facing a potential suspension after yesterday’s controversial sticky stuff ejection. He’s planning to appeal a suspension if he’s ultimately given one, but if it’s upheld or he ultimately drops the appeal, the Mets will have to play shorthanded for the duration of his absence as players suspended for on-field violations aren’t allowed to be replaced on the roster.
Despite all of this turmoil, the Mets are holding their own with a 12-7 record so far. For now, the rotation consists of Scherzer, Senga, Tylor Megill and David Peterson, leaving them one short of a typical five-man mix. Senga is starting today but it’s not currently known who’s taking the ball tomorrow. José Butto made a spot start this week but was optioned after, meaning he can’t come back for 15 days unless someone else gets placed on the injured list. Elieser Hernández hasn’t pitched yet in the majors or minors this year due to a shoulder strain. Dylan Bundy was signed to a minor league deal a few weeks ago and made his first Triple-A start this week, though he was torched for nine runs in 4 1/3 innings.
Joey Lucchesi might get a call at some point since he’s on the 40-man roster and stretched out, tossing 6 2/3 scoreless innings in his most recent Triple-A start. He missed all of 2022 recovering from Tommy John surgery but has been an effective starter in the past. He made 56 starts for the Padres in 2018 and 2019, posting a 4.14 ERA with a 24.6% strikeout rate, 8% walk rate and 46% ground ball rate. Injuries have limited him to a few ineffective outings in the years since, but he has a 2.30 ERA through three Triple-A starts so far this year.
With the club blasting through their depth options in the early going, they’ve decided to stretch out Denyi Reyes, per Sammon. He had been pitching well out of the bullpen for the big league club, throwing 6 1/3 scoreless innings so far, but he was optioned yesterday to get some work as a starter in Triple-A and provide the Mets with another depth option. He had some success as a starter as a prospect in the lower levels of the minors but didn’t really thrive when he reached higher levels, gradually getting push to more bullpen work. His only Triple-A action came in the Orioles’ system last year, where he posted a 7.17 ERA over 10 starts and five relief appearances.
Given all of these moving parts, the Mets would surely prefer Carrasco can return after a brief rest period, as opposed to needing surgery and requiring a longer absence. He’s dealt with various injuries throughout his career but generally returns to effectiveness when healthy. Last year, he made 29 starts for the Mets and posted a 3.97 ERA with a 23.6% strikeout rate, 6.4% walk rate and 46% ground ball rate. The Mets had to decide between $14MM club option to keep him around and a $3MM buyout, ultimately deciding to trigger the option. He’s set to become a free agent for the first time at the end of this year, having twice signed extensions with Cleveland before getting traded to the Mets alongside Francisco Lindor.
